Brief: MaxCyte Q3 Revenue USD 6.4 Million Vs. IBES Estimate USD 8.37 Million
05/11/2025 13:05
Nov 05 (Reuters) - MaxCyte Q3 cash & investments USD 158 million.
Recent news on MaxCyte
See all newsMaxCyte Q1 revenue falls
Brief: Maxcyte Appoints Parmeet Ahuja As Chief Financial Officer
Brief: Maxcyte Announces Preliminary Unaudited Fourth Quarter And Full Year 2025 Financial Results
MaxCyte Q3 revenue falls 16% hurt by lower sales in instruments
Brief: MaxCyte Announces Planned CFO Transition In 2026